One promising approach to meet the growing problem of antibiotic resistance is to modulate host defense mechanisms, i.e., host-directed therapy (HDT), in the fight against infections. Induction of endogenous antimicrobial peptides (AMPs) via small molecular compounds, such as 1,25-dihydroxyvitamin D3 or phenylbutyrate, could provide one such HDT-based approach. We have developed a cell-based screening assay for the identification of novel compounds with the capacity to induce AMP expression and here follows the detailed protocol.
CITATION STYLE
Nylén, F., Bergman, P., Gudmundsson, G. H., & Agerberth, B. (2017). Assays for identifying inducers of the antimicrobial peptide LL-37. In Methods in Molecular Biology (Vol. 1548, pp. 271–281). Humana Press Inc. https://doi.org/10.1007/978-1-4939-6737-7_19
Mendeley helps you to discover research relevant for your work.